BioNTech vs Tenet Healthcare
BioNTech (BNTX), health care, and Tenet Healthcare (THC), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Tenet Healthcare is worth $22.4B on the stock market and BioNTech $21B: Tenet Healthcare is valued at 7% more. BioNTech's operating margin in its latest fiscal year was -49.0% and Tenet Healthcare's 16.5%. Over the past year BioNTech's share price has moved -16.8% and Tenet Healthcare's +51.1%.
Key facts
- BioNTech market value
- $21B
- Tenet Healthcare market value
- $22.4B
- Tenet Healthcare P/E
- 8.2
- BioNTech revenue
- $3.2BFY to 2025-12-31
- Tenet Healthcare revenue
- $21.3BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | BioNTech | Tenet Healthcare |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $21Blower | $22.4Bhigher |
| Revenue | $3.2Blower | $21.3Bhigher |
| Earnings | -$1.3Blower | $2.4Bhigher |
| Employees | 7,807lower | 77,000higher |
| Total assets | $24.4Blower | $29.7Bhigher |
| Valuation | ||
| P/E | — | 8.2 |
| P/S | 6.6higher | 1.1lower |
| P/B | — | 4.1 |
| Dividend yield | — | 0.00% |
| Profitability | ||
| Operating margin | -49.0%lower | 16.5%higher |
| Balance sheet | ||
| Net assets | $21.3Bhigher | $4.2Blower |
| Total liabilities | $3.1Blower | $20.7Bhigher |
| Total debt | — | $13.3B |
| Cash on hand | $8.5Bhigher | $2.9Blower |
| Price change | ||
| Today | -0.47%higher | -3.25%lower |
| 1 year | -16.8%lower | +51.1%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
BioNTech only (4)
- Temasek0.3%
- Primecap team0.2%
- Dodge & Cox team0.2%
- Julian and Felix Baker0.1%
Tenet Healthcare only (3)
- Larry Robbins8.4%
- Ken Griffin0.2%
- Bill Nygren<0.1%
Percentages are each holding's share of that investor's reported portfolio. Who owns BNTX · Who owns THC
More on BioNTech
Further comparisons
BioNTech against its closest peers
Tenet Healthcare against its closest peers
Learn
Questions and answers
Which is bigger, BioNTech or Tenet Healthcare?
By market value, Tenet Healthcare is the larger: $22.4B against $21B for BioNTech. By revenue in its latest fiscal year, Tenet Healthcare is the larger: $21.3B against $3.2B for BioNTech.
Which has the higher operating margin?
Tenet Healthcare: 16.5%, against -49.0% for BioNTech. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which superinvestors own both BioNTech and Tenet Healthcare?
None of the tracked superinvestors holds both in their latest 13F filing. 4 hold BioNTech and 3 hold Tenet Healthcare.
Cite this page
Funkfolio, “BioNTech vs Tenet Healthcare”, data as of 18 November 2026. https://funkfolio.com/compare/bntx-vs-thc
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.